News in the Life Sciences Industry | |
Results 141 - 160 out of 254 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 » |
Innovent Reports Interim Results for Fiscal Year 2019 |
SUZHOU, China, Aug. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced its interim financial results for the six months ended June 30, 2019. Read more ›› |
By: PR Newswire Association LLC. - 29 Aug 2019 |
Related companies: Innovent Biologics Co., Ltd. |
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9 |
Read more ›› |
By: Nasdaq / GlobenewsWire - 28 Aug 2019 |
SI-BONE to Present at the 17th Annual Morgan Stanley Global Healthcare Conference on September 10, 2019 |
Read more ›› |
By: Nasdaq / GlobenewsWire - 26 Aug 2019 |
Financial calendar 2019/20 |
Read more ›› |
By: Nasdaq / GlobenewsWire - 26 Aug 2019 |
Novo Nordisk A/S – Share repurchase programme |
Read more ›› |
By: Nasdaq / GlobenewsWire - 26 Aug 2019 |
CStone announces first patient dosed in China for Phase I/II registrational bridging trial of avapritinib in advanced GIST |
SUZHOU, China, Aug. 26, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient in China has been dosed in the Phase I/II bridging study of avapritinib, which was discovered by CStone's partner Blueprint Medicines. This stand-alone registrational... Read more ›› |
By: PR Newswire Association LLC. - 26 Aug 2019 |
Related companies: CStone Pharmaceuticals |
Concord Medical Reports Financial Results for the First Half of 2019 |
BEIJING, Aug. 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated... Read more ›› |
By: PR Newswire Association LLC. - 24 Aug 2019 |
Related companies: Concord Medical Services (CMS) Holding Limited |
CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study |
SUZHOU, China, Aug. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received ethics approval from the Human Research Ethics Committee in Australia for the Phase I clinical trial of CS3002, and Australia's Therapeutic... Read more ›› |
By: PR Newswire Association LLC. - 23 Aug 2019 |
Related companies: CStone Pharmaceuticals |
CStone announces data from trials of CS1001, CS1002 and CS1003 to be released for the first time at 2019 CSCO Annual Meeting |
SUZHOU, China, Aug. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO, 2019 CSCO Annual Meeting) has accepted three abstracts on the clinical trials of CS1001 (Anti-PD-L1... Read more ›› |
By: PR Newswire Association LLC. - 23 Aug 2019 |
Related companies: CStone Pharmaceuticals |
Janssen Reports Positive Top-line Phase 3 Study Results of Investigational, Long-acting Injectable HIV Treatment Regimen Administered Every Two Months |
CORK, Ireland, Aug. 22, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen of its rilpivirine and ViiV Healthcare's... Read more ›› |
By: PR Newswire Association LLC. - 22 Aug 2019 |
Luye Pharma's Investigational Drug Ansofaxine Hydrochloride Extended Release Tablets to Start Clinical Trials in Japan |
TOKYO, Aug. 22, 2019 /PRNewswire/ -- Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hydrochloride Extended Release Tablets (LY03005) for the treatment of depression in Japan, with the trials expected to begin soon. Meanwhile,... Read more ›› |
By: PR Newswire Association LLC. - 22 Aug 2019 |
Related companies: Luye Pharma Group |
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China |
SUZHOU, China, Aug. 22, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for... Read more ›› |
By: PR Newswire Association LLC. - 22 Aug 2019 |
Related companies: Innovent Biologics Co., Ltd. |
BeiGene Announces U.S. FDA Acceptance and Grant of Priority Review for its New Drug Application of Zanubrutinib in Patients with Relapsed/Refractory Mantle Cell Lymphoma |
Read more ›› |
By: Nasdaq / GlobenewsWire - 21 Aug 2019 |
Related companies: BeiGene, Ltd. |
Steward Health Care Signs Long-Term Agreement with B. Braun for IV Solutions and Infusion Pumps |
Read more ›› |
By: Nasdaq / GlobenewsWire - 21 Aug 2019 |
CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting |
SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201... Read more ›› |
By: PR Newswire Association LLC. - 20 Aug 2019 |
Related companies: CStone Pharmaceuticals |
Novo Nordisk A/S – Share repurchase programme |
Read more ›› |
By: Nasdaq / GlobenewsWire - 19 Aug 2019 |
Sanofi: information concerning the total number of voting rights and shares, July 2019 |
Read more ›› |
By: Nasdaq / GlobenewsWire - 19 Aug 2019 |
Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress |
SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annual... Read more ›› |
By: PR Newswire Association LLC. - 19 Aug 2019 |
Related companies: CStone Pharmaceuticals |
CSPC Pharmaceutical Announces 2019 Interim Results |
Profit Attributable To Shareholders Increased 24.8% to RMB1,878 Million |
By: PR Newswire Association LLC. - 19 Aug 2019 |
Related companies: CSPC Pharmaceutical Group Limited |
Novo Nordisk A/S: Securities lawsuit filed in Denmark against Novo Nordisk |
Read more ›› |
By: Nasdaq / GlobenewsWire - 16 Aug 2019 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 » |
Upcoming Life Sciences Events
- December 2019
- Marseille: BioFIT
- London: Genesis 2019
- London: The Pharma Business Development Course